BGRSX
Price
$15.25
Change
-$0.00 (-0.00%)
Updated
Sep 20 closing price
DIAMX
Price
$28.86
Change
-$0.09 (-0.31%)
Updated
Sep 20 closing price
Ad is loading...

BGRSX vs DIAMX

Header iconBGRSX vs DIAMX Comparison
Open Charts BGRSX vs DIAMXBanner chart's image
Boston Partners Global Long/Short I
Price$15.25
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Diamond Hill Long-Short I
Price$28.86
Change-$0.09 (-0.31%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
BGRSX vs DIAMX Comparison Chart
Loading...
VS
BGRSX vs. DIAMX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGRSX is a Buy and DIAMX is a StrongBuy.

FUNDAMENTALS
Fundamentals
DIAMX has more cash in the bank: 1.83B vs. BGRSX (164M). DIAMX pays higher dividends than BGRSX: DIAMX (1.83) vs BGRSX (1.25). BGRSX was incepted earlier than DIAMX: BGRSX (10 years) vs DIAMX (24 years). BGRSX is a more actively managed with annual turnover of: 172.00 vs. DIAMX (41.00). BGRSX (2500) and DIAMX (2500) have matching initial minimum investment requirements. BGRSX (14.67) and DIAMX (14.17) have marching annual gain over last year. BGRSX return over 5 years is better than : 59.93 vs. DIAMX (9.82).
BGRSXDIAMXBGRSX / DIAMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years24 years-
Gain YTD10.62010.581100%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets164M1.83B9%
Annual Yield % from dividends1.251.8368%
Returns for 1 year14.6714.17104%
Returns for 3 years42.21-1.38-3,053%
Returns for 5 years59.939.82610%
Returns for 10 years66.9925.92258%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMPL33.600.09
+0.27%
Simply Good Foods Company (The)
NOK4.19N/A
N/A
Nokia Corp
EPM5.61-0.12
-2.09%
Evolution Petroleum Corp
AYTU2.47-0.06
-2.37%
Aytu BioPharma
CTKB5.06-0.28
-5.24%
Cytek Biosciences